NEWS - Changes to Blood Glucose Meters


PHARMAC have announced their new funding decision for diabetes management products. We are sharing this information as it’s relevant for people with diabetes and those who care for them. However, we do not endorse the decision by PHARMAC to fund a sole supply of self-monitoring diagnostic test meters for people with diabetes.


People with diabetes, particularly those with Type 1 diabetes, have been clear about the desire and need for choice and this decision is not in line with these needs. Our role at Diabetes NZ is to advocate for the best care and management for all New Zealanders living with diabetes.


Although we understand PHARMAC’s decision making processes, we still strongly believe that the savings of $10million over 5 years as a result of this decision should go towards fully funded Continuous Glucose Meters (CGMs) and reinvested in improving the lives of people with diabetes.


For more information, watch the video below or for full details of the PHARMAC decision visit


NEWSSarah Keller